
The strategic approval for deploying red and near-infrared photobiomodulation protocols reinforces their efficacy in treating conditions such as joint pain, osteoarthritis, and hair thinning, amid user caution regarding sleep enhancement. Key findings indicate consistent safety under established dosing guidelines, with a lack of credible concerns over adverse effects, allowing for continued development and research into optimal delivery mechanisms. As the medical community embraces these therapies for nonpharmacologic pain management, user sentiment remains positive, paving the way for broader acceptance and application.
“the Eyerising International device which has gained regulatory approval in several countries and has been reported to have been used for more than 100,000 children for red laser therapy in China...”
“According to Dr. Engelman, red and near-infrared light work at the mitochondrial level and stimulate energy production inside cells, which can support collagen synthesis, improve circulation, and reduce inflammatory signaling.”
“Red light therapy (aka low-level light therapy, or LLLT) is marketed as a way to stimulate hair growth, increase hair thickness, and slow the progression of thinning.”